Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation

Technology appraisal guidance
Reference number: TA256
Published: 23 May 2012
Last updated: 02 July 2021

Atrial fibrillation (stroke prevention) - rivaroxaban: comments on the ACD received from the public through the NICE website

Atrial fibrillation (stroke prevention) - rivaroxaban: comments on the ACD received from the public through the NICE website

Atrial fibrillation (stroke prevention) - rivaroxaban: comments on the ACD received from the public through the NICE website
30 March 2012
(308.79 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 29 March 2012